×

×
=

News

News

Week Ahead - 11th - 15th January 2021

Establishing a Recovery and Resilience Facility; The EU’s Vaccine Strategy and Concerns about Slow-Moving Vaccine Deployment; EU-UK deal.

Establishing a Recovery and Resilience Facility

On Monday, the Budget Committee and the Committee on Economic and Monetary affairs will hold a joint meeting on the inter-institutional negotiations on the Recovery and Resilience Facility and the InvestEU programme. The ECR co-rapporteur, Roberts Zīle, is of the opinion that the draft agreement on the RRF is a balanced approach towards support for reforms and investments undertaken by Member States although the final draft agreement will be much more in line with the Council’s initial position as the Parliament’s positions.

When: Monday @ 16:30

The EU’s Vaccine Strategy and Concerns about Slow-Moving Vaccine Deployment

The Committee on the Environment, Public Health and Food Security will have an extraordinary meeting with Sandra Gallina, Commission Director-General of Health and Food Safety (DG SANTE), lead negotiator on COVID-19 vaccines contracts. The ECR agrees with the concerns raised by several Member States about the Commission’s approach in its Vaccination Strategy, which has left the EU’s immunisation plans lagging behind countries such as the U.K., the U.S. and Israel.

When: Tuesday @ 9:00

EU-UK deal

The Committee on International Trade and the Committee on Foreign Affairs will begin its scrutiny of the EU-UK trade and cooperation agreement this week. The ECR Group welcomed the deal based on zero tariffs and zero quotas throughout the negotiations. The ECR Group understands the logic of the extension of the provisional application period beyond 28 February. However, the Conservatives and Reformists would like to appeal to all political groups and committees to proceed with pragmatism and flexibility to ensure it possible even to ratify the agreement during the plenary session in February.

When: INTA Monday @ 16:45

AFET & INTA Thursday @ 10:00

  • SHARE
  • Email
  • Facebook
  • Twitter